JS105

Other Medications

Description

Detailed description is being prepared by our clinical team.

Clinical Trials

NCT06208410 Phase 1
Recruiting
A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors
China